SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care ®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...
Tandem Diabetes Care, Inc. TNDM recently announced that bolus insulin dosing on the t:slim X2 insulin pump utilizing the t:connect mobile app has been cleared by the FDA. With this approval, the ...
Feb. 18 (UPI) --The U.S. Food and Drug Administration has cleared the first smartphone app to deliver insulin using the t:connect app from Tandem Diabetes Care, Inc. "This FDA clearance further ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback